$2.91
-0.01-0.34%
Nasus Pharma Ltd
NSRXAMEX
Nasus Pharma (NSRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| H1 | Aug 17, 2026 | $-0.54 | $-0.20 | -170.0 % |
| FY | Mar 25, 2026 | $-0.72 | $-0.19 | -278.9 % |
| H1 | Dec 29, 2025 | $-0.17 | $-0.14 | -21.4 % |
Quarterly Revenue (Billions)
| Metric | H1 '26 | H1 '25 | FY '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.20 | $-0.14 | $-0.19 |
| Actual | $-0.54 | $-0.17 | $-0.72 |
| Surprise | -170.0% | -21.4% | -278.9% |
| Revenue | |||
| Estimate | — | — | — |
| Actual | $0 | $0 | $0 |
| Surprise | — | — | — |
| Metric | FY '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-1.07 |
| Revenue | |
| Consensus | — |
